If you would like to join the team at ProQR but you can't find the right job opening at this moment, you are welcome to send us an open application via our connect portal!
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
… Science At ProQR science is literally at the heart of what we do. Our … and translating them to life-changing treatments. At ProQR science is literally at the heart of what we do. The … with rare genetic diseases. Axiomer RNA base editing At ProQR we invented the Axiomer™ technology that enables single …
At ProQR, we are dedicated to improving the lives of patients and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology.
This website contains forward-looking statements about potential therapeutic uses and effects of ProQR Therapeutics’ products, including but not limited to our technologies.
Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
